Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,261,203 papers from all fields of science
Search
Sign In
Create Free Account
Hepatitis, Toxic
Known as:
Toxic hepatitis
, Hepatitides, Toxic
, HEPATITIS TOXIC
Expand
INFLAMMATION of the LIVER due to hepatocellular toxicity, caused by drug metabolites and chemicals from the environment.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (3)
Chemical and Drug Induced Liver Injury
Poisoning
hepatobiliary disease
Hepatitis, Drug-Induced
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Evaluating the mobility of toxic metals in untreated industrial wastewater sludge using a BCR sequential extraction procedure and a leaching test
T. Kazi
,
M. K. Jamali
,
G. H. Kazi
,
M. B. Arain
,
H. I. Afridi
,
A. Siddiqui
Analytical and Bioanalytical Chemistry
2005
Corpus ID: 23145272
The distribution and speciation of toxic metals in industrial wastewater sludge (IWS) was investigated. In this work, the…
Expand
Review
2003
Review
2003
EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer.
Lazzaro Repetto
,
L. Biganzoli
,
+4 authors
Matti Aapro
European Journal of Cancer
2003
Corpus ID: 46162239
Review
2001
Review
2001
Chemicals and biological products used in south-east Asian shrimp farming, and their potential impact on the environment--a review.
Sara Gräslund
,
B. Bengtsson
Science of the Total Environment
2001
Corpus ID: 19814993
Review
1998
Review
1998
Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel.
M. Bookman
,
H. Malmström
,
+4 authors
S. Fields
Journal of Clinical Oncology
1998
Corpus ID: 34727443
PURPOSE Topotecan, a topoisomerase I inhibitor, was evaluated in a multicenter, phase II study of women with epithelial ovarian…
Expand
Review
1998
Review
1998
In vitro techniques for the assessment of neurotoxicity.
G. Jean Harry
,
M. Billingsley
,
+7 authors
Hugh A. Tilson
Environmental Health Perspectives
1998
Corpus ID: 17278289
Risk assessment is a process often divided into the following steps: a) hazard identification, b) dose-response assessment, c…
Expand
Review
1995
Review
1995
Race, class, and environmental health: a review and systematization of the literature.
P. Brown
Environmental Research
1995
Corpus ID: 27102173
This paper analyzes and systematizes the race and class differentials in exposure to toxic hazards and actual health outcomes…
Expand
Review
1994
Review
1994
Designing microorganisms for the treatment of toxic wastes.
K. Timmis
,
R. Steffan
,
R. Unterman
Annual Review of Microbiology
1994
Corpus ID: 45331158
The genetic design of novel metabolic routes offers exciting possibilities for biological research and biotechnology, both in the…
Expand
Highly Cited
1991
Highly Cited
1991
Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease.
D. Reece
,
M. Barnett
,
+7 authors
C. Lemaistre
Journal of Clinical Oncology
1991
Corpus ID: 42823397
Fifty-six consecutive patients with advanced Hodgkin's disease considered incurable with further conventional chemotherapy were…
Expand
Highly Cited
1989
Highly Cited
1989
Expression of an intercellular adhesion molecule, ICAM-1, by human thyroid cells.
A. Weetman
,
S. Cohen
,
M. Makgoba
,
L. Borysiewicz
Journal of Endocrinology
1989
Corpus ID: 24941983
Intercellular adhesion molecule-1 (ICAM-1), hitherto identified on activated B cells, macrophages, dendritic cells, endothelia…
Expand
Highly Cited
1974
Highly Cited
1974
Cutaneous and Ocular Reactions to Practolol
A. G. K. D. L. Frantz
,
.. R. Progress
,
+17 authors
M. Dahl
British medical journal
1974
Corpus ID: 29022882
A total of 21 patients suffering from drug-induced rashes from practolol have been seen over the past two years. The clinical…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required